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Abstract 
Here we report on the development of a breakthrough microfluidic human in vitro cerebrovascular 
barrier (CVB) model featuring stem cell derived brain like endothelial cells (BLECs) and nanoporous silicon 
nitride (NPN) membranes (µSiM-CVB). The nanoscale thinness of NPN membranes combined with their 
high permeability and optical transparency make them an ideal scaffold for the assembly of an in vitro 
microfluidic model of the blood-brain barrier (BBB) featuring cellular elements of the neurovascular unit 
(NVU). Dual-chamber devices divided by NPN membranes yield tight barrier properties in BLECs, and allow 
an abluminal pericyte-co-culture to be replaced with pericyte-conditioned media. With the benefit of 
physiological flow and superior imaging quality, the µSiM-CVB platform captures each phase of the multi-
step T-cell migration across the BBB in live cell imaging. The small volume of < 100 µL of the µSiM-CVB will 
enable in vitro investigations of rare patient derived immune cells with the human BBB. The µSiM-CVB is a 
breakthrough in vitro human BBB model to enable live and high quality imaging of human immune cell 
interactions with the BBB under physiological flow. We expect it to become a valuable new tool for the 
study of cerebrovascular pathologies ranging from neuroinflammation to metastatic cancer.  
 
 
Keywords: blood-brain barrier, microfluidics, nanoporous silicon nitride membrane, two-compartmental 
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Introduction 
The endothelial blood-brain barrier (BBB) in central nervous system (CNS) parenchymal microvessels 
protects the CNS from the constantly changing milieu in the blood stream. Low pinocytotic activity, 
complex and molecularly distinct tight junctions combined with expression of specific transporters and 
enzymes make BBB endothelial cells biochemically unique 1. Importantly, development and maintenance 
of BBB characteristic in CNS microvascular endothelium is not an intrinsic characteristic but rather relies 
on the continuous cross-talk with cellular and acellular components of the neurovascular unit 1.  In 
addition to strictly controlling the movement of molecules across its interfaces the BBB also rules the 
entry of immune cells and immune mediators into the immune privileged CNS 2. While under physiological 
conditions, immune cell entry into the CNS is very low, in CNS inflammatory diseases such as multiple 
sclerosis (MS) BBB function is impaired and high numbers of immune cells infiltrate the CNS, where they 
cause inflammation, and demyelination 3. Therapeutic inhibition of immune cell entry into the CNS has 
proven beneficial for the treatment of MS 4. Unfortunately, these therapies come with the rare but severe 
side effect of progressive multifocal leukoencephalopathy (PML), which is caused by infection of human 
oligodendrocytes with the JC virus and can thus not be modeled in animals. Furthermore, a number of 
anti-inflammatory treatments that were highly effective in animal models for MS, have failed in MS trials 
5, underscoring that the autoimmune pathogenesis underlying MS including BBB dysfunction and immune 
cell entry into the CNS cannot be modelled in their entire complexity in available animal models. 
Therefore, there is an unmet need for detailed functional studies employing human disease-relevant 
tissues and cells. This includes the necessity for human models of the BBB allowing the study of its 
function and the migration by disease-relevant immune cell subsets across the cellular barrier as a critical 
step in MS pathogenesis.  
Most well-characterized BBB culture models are based on primary brain endothelial cells or brain 
endothelial cell lines from animal origin (bovine, porcine and murine) 6-8. Although elegant human in vitro 
BBB models employing primary human brain endothelial cells have been established 9 their availabilities 
are limited to few laboratories with privileged access to human brain tissue. Thus, human brain 
endothelial cell lines like the hCMEC/D3 have been established and widely used as in vitro models of the 
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human BBB 10, 11. Although hCMEC/D3 retain morphological and functional characteristics of human brain 
endothelium, they fail to establish barrier characteristics resembling their tightness observed in BBB in 
vivo 12. This limits the suitability of hCMEC/D3 for pharmacological, toxicological and functional assays on 
the human BBB with in vivo predictability.  
Recently, stem cell sources have demonstrated substantial advantage over other brain endothelial cells 
sources for BBB modeling given their human origin, stability, scalability, self-renewal and potential to 
generate syngeneic cellular components of the neurovascular unit 13, 14. While inducible pluripotent stem 
cell (iPSC) derived in vitro BBB models establish very tight barrier properties their immune phenotype has 
not been well established. We have recently employed cord blood CD34+ hematopoietic stem cells to 
differentiate endothelial cells (ECs)15. By co-culturing CD34+ -derived ECs with bovine pericytes we were 
able to differentiate those ECs into brain-like endothelial cells (BLECs) providing a valuable in vitro model 
for the human BBB 15. Growing BLECs on conventional cell culture filter inserts in co-culture with 
pericytes, we and others used both small molecule diffusion and transendothelial electrical resistance to 
establish that BLECs form tight barriers, show robust expression of BBB signature molecules 15, 16 and 
express adhesion molecules supporting T-cell trafficking across the BBB17. In combination with their large-
scale availability, BLECs are therefore the ideal culture platform to study the interaction of human 
immune cells with the human BBB in vitro 17.  
Live cell imaging on glass coverslips has been used historically as the means of monitoring immune cell 
migration across endothelial monolayers in vitro under static and flow conditions 18-21. As glass coverslips 
are impermeable, they are not suited for establishing in vitro BBB models that rely on the cross talk 
between brain microvascular endothelial cells in a luminal compartment and CNS derived factors in an 
abluminal compartment 22, 23. On the other hand, the imaging qualities of permeable polymer track-etched 
(TE) membranes used in filter inserts are too poor to study immune cell interactions with the BBB in vitro 
by live cell imaging. Several studies have also demonstrated that physiological shear forces are key to the 
multi-step process of T-cells diapedesis 8, 24, 25. Thus the ideal platform for the study of dynamic T-cell 
interactions with the BBB is a membrane-based flow microfluidic system with glass-like imaging quality.  
Here we report on the development of a novel in vitro platform, the µSiM-CVB, for the study of the 
 5 
interaction of human T cells with human in vitro models of the BBB. The enabling component of this 
platform is ultrathin nanoporous silicon nitride (NPN), a 50 nm thick ‘nanomembrane’ with a high density 
(1010 cm-2; 20% porosity) of ~ 40 nm pores 26, 27. The thinness and high porosity of NPN result in a 
luminal/abluminal divider with extraordinary small molecule permeability 27, 28 and the sub-optical pore 
sizes of NPN provide outstanding imaging characteristics. We establish that CD34+ stem cell derived ECs 
differentiate into BLECs when cultured on NPN with pericyte-conditioned medium supplied basolaterally, 
eliminating the confounding effects of subluminal cell cultures on imaging.  Finally, we demonstrate the 
utility of the µSiM-CVB by capturing each phase of multi-step T-cell migration across the BBB using live cell 
imaging under physiological flow.  
 
Material and Methods 
Device Fabrication 
The enabling feature of our engineered devices used in this study is nanoporous silicon nitride (NPN) 
membranes, also referred to as silicon nanomembranes. The details of the fabrication of these 
membranes are provided elsewhere 26, and are commercially available at SiMPore Inc., West Henrietta, 
NY. The overall dimension of the NPN membrane is 5.4 x 5.4 x 0.3 mm3 and the permeable freestanding 
‘window’ of the chip is 2 mm x 0.7 mm x 0.05 mm (50 nm) and have an average pore diameter of 50 nm.  
The microfluidic device used for static and dynamic assays consist of 2 compartments: apical and basal, 
separated by the permeable membrane chip in between. The apical and basal fluidic compartments or 
channels are composed of transparent 300 microns silicone gaskets (Specialty Silicone Fabricators, CA). 
The different layers of the static and flow devices are shown in Figures 3 and 4 respectively. The channels 
and the silicon chip are irreversibly bonded to each other by exposing them to UV-Ozone for 10-15 
minutes followed with curing at 70°C for 2 hours. The fluidic access ports for these devices are provided 
by a thick slab of poly dimethyl siloxane (PDMS) (Sylgard 184, Dow Corning). Flow devices have 4 access 
ports (~1mm holes punched in the PDMS blocks): 2 for the apical chamber and 2 for the basal chamber, 
while “Transwell mimetics” only have access ports for the basal chamber. Upper PDMS blocks also have 
wider punched holes that act as media reservoirs to support cell culture in both types of devices, and are 
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bonded to the remaining device using same UV-Ozone treatment. 
 
CD34+ cell derived in vitro BBB model  
CD34+ cells were isolated from human umbilical cord blood (UCB) according to a protocol previously 
reported 29. The isolation of CD34+ cells required the collection of human umbilical cord blood (UCB) from 
infants. According to the articles L.1243-3 and R.1234-49 of the French legislation regarding the collection, 
use for Research of tissues and cells coming from human body and its derivatives, organs and blood, UCB 
collection was approved by the Hospital ethical committee (Béthune Maternity Hospital, Béthune, 
France). The protocol regarding the use of human tissues and cells was authorized by the French Ministry 
of Higher Education and Research (CODECOH Number DC2011-1321). CD34+ cells isolated from the UCB 
were differentiated in ECM basal medium (ScienCell) supplemented with 20% (v/v) fetal bovine serum 
(FBS; Life Technologies) and 50 ng/mL of VEGF165 (PeproTech Inc.), on 1% (w/v) gelatin-coated 24 well 
plates (2x105 cells/well). After 15-20 days ECs are seen in the culture dish. For each experiment, the cells 
were expanded in 0.2% (w/v) gelatin-coated 100 mm Petri dishes (Corning) in ECM basal medium 
supplemented with 5% FBS, 1% endothelial cell growth supplement (ECGS; ScienCell) and 50 µg/mL 
gentamycin (Biochrom AG). 
Induction of BBB like characteristics in CD34+ -derived endothelial cells was achieved by co-culture with 
bovine pericytes as described before 15 and elaborated on in Supplementary Methods.  
 
Endothelial Permeability (Pe) and stimulation 
Endothelial permeability was investigated by measuring the clearance of Lucifer yellow (LY; 20 nM; Life 
technologies) across the BLECs monolayer exactly as described 15, 30-32 and elaborated in Supplementary 
Methods. Pro-inflammatory conditions were induced by stimulation with 10 ng/ml human recombinant 
tumor necrosis factor-α (TNF-α, 210-TA, R&D Systems, Inc.) for 16 to 20h prior to the experiments.  
 
Immunofluorescence stainings of BLECs 
For staining in the Transwell filter inserts, BLECs were fixed in 1% (w/v) formaldehyde and permeabilized 
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in Triton X-100 (0.1% (w/v) at room temperature (RT). Then filter membranes were blocked for 30 min with 
skimmed milk 5% (w/v) in PBS. BLEC monolayers were incubated for 1h at RT with antibodies against anti-
zonula occludens-1 (ZO-1) or VE-Cadherin. For claudin-5 staining, BLECs were fixed in methanol at -20°C for 
30s prior to the staining procedure. For ICAM-1, ICAM-2 and VCAM-1, live BLECs were incubated with 10 
µg/ml of the respective antibody for 20 min at 37°C in the culture medium, fixed and permeabilized as 
described17. Secondary antibodies were incubated for 30 min at RT. For F-Actin staining, after Triton 
permeabilization, cells were incubated with rhodamine-labeled phalloidin for 1h at RT. Nuclei were stained 
with DAPI at 1 µg/mL. 
For BLECs staining on NPN membranes live cells were incubated with 10 µg/ml of anti-ICAM-1, ICAM-2, or 
VCAM-1 antibody for 20 min at 37°C in the culture medium. Then BLECs were fixed and permeabilized 
according to the Transwell inserts protocol. For the claudin-5 and F-actin staining, the same protocol as 
for BLECs staining on Transwell filters was applied. After PBS washes secondary antibodies were incubated 
for 30 min at RT. A detailed protocol is included in Supplementary Methods. 
 
Human peripheral blood T cells 
Human CD4+CD45RO+ T helper 1 (Th1) cells were obtained by fluorescence activated cell sorting from the 
peripheral blood of healthy donors according to their specific expression pattern of chemokine receptors 
(CXCR3+, CCR4neg CCR6neg) exactly as previously described 33, 34. Th1 cells were cultured in the presence of 
interleukin -2 (IL-2, 500U/ml) for a total of 20 days. At the day of the experiment dead cells were removed 
by a Ficoll gradient (780g, 20 min, 20°C) and Th1 cells were resuspended in migration assay medium 
(DMEM w/o phenol red, Hepes 25mM, Foetal Bovine Serum 5%, L-glutamine 4mM) at 1x106 cells/mL. 
 
In vitro live cell imaging 
BLECs were grown to confluency in ECM basal medium supplemented with 5% FBS, 1% ECGs and 50 
µg/mL gentamycin for 6 days as described before and stimulated or not 16 h to 20 h prior to the assay 
with TNF-α at 10 ng/mL (R&D System, 210-TA). Flow was applied by connecting the outlet tubing to a 
syringe automatically drawn up by a precision pump (Harvard Apparatus, Holliston, MA, USA). The flow 
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rate was calculated as described in 18. To allow for the accumulation of sufficient Th1 cells on the BLECs 
monolayer, Th1 cells were first infused with a flow rate of 0.1 dyne/cm2 for 4 min (accumulation phase). 
After the accumulation phase, the tap is switched to infuse migration assay medium only and the flow 
rate was increased to 1.5 dyne/cm2 for 30 min (shear phase). T-cell interaction with the BLECs was 
recorded for 30 min in time lapse mode (1 picture/5 s) using the microscopic equipment that has been 
described in depth before 18 with the ZEN blue software. Video editing was performed with the software 
“Adobe After Effect” allowing to export the image sequences as videos running at 30 frames/s as well as 
to edit the videos to show the different T cell behavior with the BLECs. Fiji software was used to classify 
the T cell behavioral categories observed on the BLECs under physiological flow (diapedesis, crawling, 
probing and detaching). 
 
Statistical analysis 
Data are shown as the mean ± SD. Statistical significance was assessed by Student’s t-test or one- way 
ANOVA followed by Dunett’s post hoc test. For multiple comparison p-values are indicated in the 
corresponding figures (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). Statistical analyses 
comprising calculation of degrees of freedom were done using GraphPad Prism 6 software (Graphpad 
software, La Jolla, CA, USA). 
 
Results 
Commercial supports are not suitable for live cell imaging of the human in vitro BBB model under 
physiological flow  
We have previously developed a custom-made flow chamber that allowed us to observe the interaction of 
immune cells with an in vitro model of the mouse BBB established from primary mouse brain 
microvascular endothelial cells (pMBMECs) by live cell imaging 18. More recently, we adapted this flow 
chamber to allow the insertion of commercially available filter membranes 35. In addition to a significant 
reduction in imaging quality, we found that the commercial TE membranes could not support the 
formation of BLEC monolayers or that they immediately resulted in the detachment of the monolayer 
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with the onset of flow (Supplementary videos 1-4). We found similar negative results with 6 commercially 
available polymer filters (Supplementary table 1) even with the addition of MatrigelTM, laminins, collagens 
or fibronectin coatings. 
A review of experimental microfluidic culture devices described in the literature also suggests that these 
would not provide ready solutions to our needs. Most generally, these systems are not amenable to live 
cell observations of T cell/BLEC interactions due to the lack of membrane transparency 36, 37, and/or due to 
the fact that the endothelial cell interface is grown vertically 38 or on the luminal surface of tubings 39-41. 
Moreover, some of these systems employ large amounts of fluid volume to maintain flow over time 36, 37, 
42, which would limit our ability to study the interaction of a limited number of patient derived T-cell 
subsets with BLECs. We concluded that both a novel membrane and microfluidic device were needed for 
live cell imaging of dynamic human T-cell/BBB interactions in vitro.  
 
CD34+-derived ECs adhere and grow on nanoporous silicon nitride membranes  
We established that CD34+-derived ECs readily adhered to and built a confluent monolayer on MatrigelTM-
coated nanoporous silicon nitride (NPN) under static conditions and that NPN provided glass-like clarity of 
monolayers in phase contrast microscopy (Fig. 1). NPN is a recently developed ultrathin silicon membrane 
technology 26 and the third generation of ultrathin porous ‘nanomembranes’ developed using silicon 
manufacturing techniques 28, 43. NPN membranes are 50 nm thick with ~20% porosity and a narrow 
distribution of pores centered around 40 nm. NPN is far more mechanically and chemically robust than 
our original porous nanocrystalline silicon membranes 26, and unlike microporous SiO2 membranes 43, 44, 
the nanoscale pores of NPN are invisible to light microscopy. Importantly, we have found that NPN 
supports vascular endothelial cell adhesion under physiological shear stress, while microporous SiO2 
nanomembranes do not (Supplemental Figure S1) , perhaps related to the fact that micron-scale pores 
disrupt the normal architecture of basement membranes 45. 
 
Pericyte co-culture can be replaced by pericyte-conditioned medium to induce BBB characteristics in 
CD34+-derived ECs  
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Co-culture of CD34+-derived ECs with pericytes is essential for induction of BBB characteristics as complex 
tight junctions and expression of transporters 15. However, shadows from out-of-focus pericytes in the 
basal chamber impair imaging of T-cell/endothelial interactions in a co-culture system. Thus to improve 
the imaging quality at the endothelial layer, we asked if the pericyte-co-culture could be simply replaced 
with conditioned medium from the pericyte cultures. To this end, we co-cultured CD34+-derived ECs with 
or without pericytes in the original Transwell filter co-culture setup for 5 days as positive and negative 
control, respectively. In parallel, CD34+-derived ECs plated on additional matrigel coated Transwell filter 
inserts were co-incubated with pericyte-conditioned medium (PCM) from the abluminal (lower 
compartment) or luminal (upper compartment) side (Fig. 2A,B) and subsequently replaced on a daily basis 
by alternating between 24h and 48h. In order to obtain the PCM, 2.25x104 /well pericytes were seeded 
into 24-well Costar plates one day prior to seeding the CD34+ -derived ECs. After the adhesion of the 
CD34+ -derived ECs on the Matrigel coated Transwell filter inserts, the 24 hours PCM was collected from 
the pericyte cultures and administered to the luminal or abluminal side of the CD34+ -derived ECs (Fig. 
2A,B) and subsequently replaced on a daily basis by alternating between 24h and 48h PCM to ensure an 
optimal concentration of the pericyte-derived factors (Fig. 2B). After 5 days of culturing the CD34+-derived 
ECs under the different conditions, their barrier characteristics were compared side-by-side by testing the 
permeability of the EC monolayers for the small molecular weight tracer lucifer yellow (LY) (Fig. 2C). In 
accordance to our previous findings the monoculture of CD34+-derived ECs did not establish a diffusion 
barrier for LY (Pe LY = 2.04 ± 0.48 x 10-3 cm/min), while the co-culture with pericytes established brain-like 
endothelial cells (BLECs) with tight barrier characteristics as shown by the significantly reduced clearance 
of LY across the EC monolayer (Pe LY = 0.52 ± 0.23 x 10-3 cm/min; Fig. 2C). PCM applied from the abluminal 
side of the CD34+-derived EC monolayer induced barrier characteristics comparable to those induced by 
the pericyte-coculture (Pe LY = 0.55 ± 0.18 x 10-3 cm/min; Fig. 2C). Interestingly, applying PCM from the 
luminal side failed to induce comparable barrier characteristics underscoring that our in vitro model of the 
BBB appropriately mimics the in vivo situation with highly polarized endothelial cells. 
To confirm junctional integrity and maturation, EC monolayers were immunostained for the 
transmembrane adherens and tight junction proteins VE-cadherin and claudin-5, respectively and the 
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junctional scaffolding protein ZO-1. Abluminal application of PCM induced a junctional architecture in 
CD34+-derived ECs comparable to that induced by co-culture with bovine pericytes 15. Specifically, the 
pericyte co-culture or the abluminally administered PCM induced a continuous and more jagged staining 
of the junctional and scaffolding proteins VE-Cadherin and ZO-1 compared to the monoculture and PCM 
luminal conditions (Fig. 2D). Moreover, junctional claudin-5 immunostaining was enhanced in BLECs under 
conditions of pericyte co-culture and in the abluminally administered PCM conditions (Fig. 2D) when 
compared to controls. F-actin staining revealed the absence of stress fibers underscoring the quiescent 
nature of the ECs monolayers (Fig. 2D). Also, BLECs in co-culture with pericytes or with abluminal PCM 
showed comparable upregulation of adhesion molecules such as ICAM-1 and VCAM-1 but not of ICAM-2 
upon addition of a pro-inflammatory stimulus eg by addition of TNF-α (Fig. 2E). Taken together, these 
results show that differentiation of CD34+-derived ECs into BLECs can be achieved by applying PCM to the 
abluminal side.  
 
CD34+-derived ECs establish BBB characteristics when grown on NPN membranes 
In a next step, we asked if PCM induced barrier characteristics in CD34+-derived ECs also occurred when 
the cells were grown on NPN membranes. The silicon chip platform of nanomembranes makes it easy to 
create customized, tightly bonded microfluidic devices using layer-by-layer assembly and ozone based 
activation of silicone/PDMS layers 46, 47. Thus, for these purposes, we fabricated a "Transwell® mimetic”, in 
which a NPN membrane divides an upper and lower compartment in static culture (Fig. 3A). The 
membrane compartment of this device is open for media and reagent application from the top and 
promotes easy gas exchange for maintaining physiological pH within the media. The basal compartment 
can be accessed from fluid ports on the top of the device and is separated from the membrane 
compartment by the NPN membrane providing the sole area for exchange of factors between 
compartments. The entire device can be autoclaved and the volume requirements in the upper and lower 
compartments are only 50 µL and 20 µL respectively.  
In order to induce barrier characteristics in CD34+-derived ECs, we followed the same culture procedure as 
depicted in Fig. 2B. CD34+-derived ECs (1x105 cells/mL) were seeded on the Matrigel coated NPN 
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membrane and grown in the absence or presence of PCM applied in the basal compartment (Fig. 3B). 
CD34+-derived ECs were cultured for 5 days replacing the PCM in the basal compartment every 24 hours 
while alternating the 24h and 48h PCM. Barrier characteristics were tested after 5 days of culture by 
performing a LY permeability assay (Fig. 3B). The paracellular permeability of EC monolayers was 
evaluated as described in Supplementary Methods and the PSe was divided by a cell growing area (0,014 
cm2), in order to generate the endothelial Pe in cm/min. While CD34+ - derived ECs grown on NPN 
membranes in monocultures did not establish a tight barrier (Pe LY = 1.82 ± 0.60 x 10-3 cm/min), in the 
presence of abluminal PCM, CD34+ -derived ECs grown on NPN membranes established BLEC 
characteristics (Pe LY= 0.39 ± 0.24 x 10-3 cm/min; Fig. 3B), comparable to BLECs grown on Transwell filter 
inserts (Fig. 2A). Induction of BLEC properties grown on NPN membranes by abluminal PCM was further 
confirmed by the junctional localization of VE-cadherin, claudin-5 and ZO-1 (Fig. 3C). Thus, NPN 
membranes are suitable for the induction of BBB properties by PCM in CD34+ -derived ECs. 
Next, we investigated cell surface expression of adhesion molecules known to mediate T-cell interaction 
with the BBB on BLECs grown on the NPN membranes. We found constitutive cell surface expression of 
the adhesion molecule ICAM-2, constitutively expressed in human endothelial cells 48 and to a lesser 
degree for ICAM-1 but not of VCAM-1 on BLECs (Fig. 3D). To mimic an inflammatory environment, BLECs 
were stimulated with tumor necrosis factor alpha (TNF-α) (10 ng/mL) for 16 h which resulted in up-
regulation of ICAM-1 and VCAM-1, as demonstrated in our previous work 17. Moreover, the TNF-α 
stimulation was inducing the formation of F-actin stress fibers as revealed by the immunofluorescence 
staining (Fig. 3D). Taken together, these results show that our human in vitro BBB model is functionally 
reproduced on NPN and suitable to investigate the role of the signature molecules involved in the T-cell 
trafficking.  
 
Establishment of a small scale human in vitro BBB model under flow: Introduction of the µSiM-CVB flow 
system  
Using the same layer-by-layer fabrication used for open “Transwell® mimetics”, we constructed a closed, 
two-chamber flow device, which we refer to as “µSiM-CVB flow system” (Fig. 4A). This new device is 
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composed of several 300 µm thick silicone layers that create the compartments necessary for the apical 
growth of the CD34+ -derived ECs and the abluminal application of PCM. The CD34+ -derived ECs are 
seeded on the silicon nanomembrane via the top channel that also serves as the flow channel. In addition, 
reservoirs have been added to the top PDMS block of the device at both ends of each channel. This allows 
the addition of excess culture medium (200 µL per channel) to prevent evaporation during prolonged cell 
culture (Fig. 4B). In order to grow the BLECs monolayer, CD34+ -derived ECs are seeded in the top channel 
on the silicon nanomembrane (1.4 mm2) at a concentration of 1x106 cells/mL. Induction of BLECs is 
achieved by the daily and alternating administration of 24h and 48h PCM for 6 days under static 
conditions, as established in the “Transwell® mimetic” system. The differentiation of CD34+ EC to BLECs in 
the µSiM-CVB flow system by application of PCM into the lower chamber could be confirmed by the 
induction of permeability values to LY (Pe LY= 0.72 ± 0.13 x10-3 cm/min) comparable to Pe LY values for 
BLECs induced with abluminal PCM in the standard Transwell® inserts and Transwell® mimetics 
(Supplemental Figure S2). Furthermore, the junctional localization of VE-cadherin, claudin-5 and ZO-1 
confirmed the BLECs junctional maturation by abluminal application of PCM in the µSiM-CVB flow system 
(Fig. 4C). 
To apply flow on the BLEC monolayer, both ends of the top channels are connected to transparent PVC 
tubing with the help of 18 gauge straight needles with the tap open to avoid any increased pressure in the 
chamber. The inlet tubing is then connected to a 3-way tap linked to 2 reservoirs respectively containing 
the Th1 cell suspension and migration assay medium, and the outlet tubing was connected to a 
programmable pump.  
With this device and scheme, it was possible to superfuse the Th1 cells over the BLEC monolayer and 
directly image the T cells in phase contrast with a transmitted light inverted microscope equipped with a 
temperature-controlled chamber (37°C), and to observe the multi-step T-cell migration across the BBB 
under physiological flow in vitro (scheme in Fig. 4D). To perform the flow experiment, first the Th1 cells 
were infused in the top channel for 4 min at a low flow rate of 0.1 dyne/cm2 to allow a first contact with 
the BLECs (accumulation phase). Then the migration assay medium only was infused and the flow rate was 
increased to 1.5 dyne/cm2 to reach a physiological shear for 30 min (shear phase) allowing the study of 
 14 
post-arrest T-cell behavior on the BLECs monolayer. In order to see if we could image the BLECs at high 
resolution and keep the focus on the cells for the duration of the flow experiment, a temporal snapshot of 
the BLECs taken from a video recorded with a 10x magnification was made, showing the first and last 
frame of a flow movie (Fig. 4E). In order to mimic conditions of the BBB under inflammatory or non-
inflammatory conditions, BLECs were pre-treated or not with TNF-α after 5 days of culture with the PCM, 
when the BBB characteristics (low permeability, mature tight junctions) were established (Fig. 3B,C), 16h 
before starting the flow experiment. First, we found that the resolution was sufficient to perfectly 
distinguish each endothelial cell in phase contrast images. We observed that treatment of BLECs with TNF-
α  induced a more elongated shape of the BLECs before flow application which additionaly modified the 
shape of the BLECs (Fig. 4E), which is in accordance with the induction of F-actin stress fibers as observed 
with the immunofluorescence staining (Fig. 3D). When starting to apply flow (0 min) the NPN membrane’s 
stiffness kept it perfectly in focus (34min55s) and allowed us to continuously image the BLEC monolayer 
under physiological flow in the same focal plane. In addition, we ensured that the monolayer stayed 
perfectly intact and in focus under physiological flow for a time period of at least 30 minutes, which is a 
prerequisite for following the T cell-BLECs interactions over time. 
Live cell imaging of the interaction of human T cells with BLECs under physiological flow 
In a final step, we employed the µSiM-CVB to study the interaction of human T cells with the human BBB 
under physiological flow following the same procedure described above. In order to illustrate how we 
could observe various types of T cell/BLEC interactions with high resolution, we generated temporal 
snapshots from a video recorded with a 20x magnification where BLECs were stimulated with TNF-α (Fig. 
5A). In addition, we also recorded videos with a 10x magnification of T cell-BLEC interactions where BLECs 
were stimulated (video 2) or not (video 1) with TNF-α. These videos allowed us to have a statistical 
comparison of the T-cell behavior on the BLEC monolayers in unstimulated and TNF-α stimulated 
conditions (Fig. 5B), since a higher number of T cells could be tracked compared to higher magnification 
videos, at the cost of a lower resolution. To analyze the respective T-cell behavior on the BLECs 
monolayers in a quantitative manner, we performed a visual frame-by-frame offline analysis of the time-
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lapse videos. To this end each T cell was categorized into a specific behavioral group. Under both, 
unstimulated and TNF-α stimulated conditions, the majority of T cells were found to polarize upon arrest 
(video 1 and 2) and to migrate across the BLEC monolayer with or without prior crawling on the BLECs. 
These were categorized under “diapedesis” (Fig. 5A). T cells that crawled on the surface of the BLECs for 
the entire observation time were categorized as “crawling” (video 1 and 2, Fig. 5A). One additional 
behavior observed was T cells that remained stationary without displacing beyond a distance exceeding 
their own diameter and presenting dynamic cellular protrusions and thus “probing” the BLEC monolayer 
(video 1 and 2, Fig. 5A). Also, some T cells were found to quickly “detach” from the BLECs monolayer 
when the flow rate increased at the beginning of the shear phase (video 2). In general, we observed a 
higher number of T cells arresting on the TNF-α stimulated BLECs versus the non-stimulated BLECs 
monolayers resulting in an increased number of T cells interacting with the TNF-α stimulated BLECs in 
each T cell behavioral category (Fig. 5B). Overall, the TNF-α stimulation favored T cell-BLECs interactions 
without modulating their behavior among categories. This observation is in accordance with the 
upregulated cell surface expression of ICAM-1 and VCAM-1 previously shown (Fig. 3D), suggesting that 
upon TNF-α stimulation, the upregulation of adhesion molecules could explain the significantly higher 
number of Th1 cells found to arrest on BLECs under physiological flow, ~4 min after starting to infuse T 
cells and just after the accumulation phase (Fig. 5B). Taken together, our novel µSiM-CVB flow system 
allows for detailed observation of the multi-step T cell extravasation across a human model of the BBB at 
a very small scale suitable for employing rare patient derived immune cells. 
 
Discussion 
The development of an in vitro platform to study the migration of immune cells across the BBB in the 
context of human CNS disorders has provided many challenges. We began addressing these challenges by 
first establishing a novel human in vitro model of the BBB from human ECs derived from cord blood CD34+ 
hematopoietic stem cells 15. We demonstrated that when co-cultured with pericytes, CD34+ EC 
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differentiate into brain-like endothelial cells (BLECs) establishing low permeability barriers and mature 
tight junctions. Due to the general availability of cord blood stem cells, BLECs can be widely adopted to 
study molecular mechanisms in pathologies implicating the BBB such as neurodegenerative or 
neuroinflammatory disorders (e.g. Alzheimer’s disease, multiple sclerosis), stroke and traumatic brain 
injury, infectious processes and inflammatory pain.  
While we have previously used BLECs to study immune cell extravasation and cancer metastatic cells 
across the BBB in static culture conditions 16, 17, 49, the application of physiological flow is needed for more 
physiological observations 8, 25. The visualization of the multi-step immune cell extravasation across the 
vascular wall requires a testing platform compatible with transmitted light microscopy, preferably phase 
contrast. The desire for flow and live-cell imaging has compelled us and others to use flow chambers with 
endothelial cells cultured on glass coverslips, as the track-etched membranes used in traditional two-
chamber filter devices are notoriously bad for imaging under transmitted light 44. This choice however, 
introduces new complications as non-permeable substrates are not physiological and are thought to 
compromise the polarization of barrier cells due to the lack of basal transport 50. In addition, these flow 
chambers are not suitable for in vitro BBB models that rely on the continuous and polarized cross-talk of 
the brain endothelial cells with cellular or acellular elements of the neurovascular unit, such as pericytes 
or astrocytes and CNS derived factors, respectively 51, 52.  
The previous decade has witnessed the emergence of customized microsystems for ‘organ-on-chip’ 
models or ‘microphysiological systems’ (MPS) 53. While a number of these efforts have focused on BBB 36-
39, 41, only Walter and colleagues 54 addressed the need for membrane transparency. Their solution was to 
employ ‘transparent’ track etched membranes that have 100 fold fewer pores than conventional 
materials (106 pores/cm2 vs 108 pores/cm2) and are more than twice as thick (23 µm vs 6 – 10 µm). While 
these membrane modifications diminish the confounding influence of pores on light transmission and 
enabled clear phase images of monolayers, they also dramatically reduce the diffusive permeability of the 
membranes by more than two orders of magnitude. Indeed, we calculated the small molecule 
permeability of the low porosity TE membranes used by Walter et al. to be 10-5 cm/s, a value lower than 
some of the permeabilities we report here for luciferase yellow transport across BLEC monolayers. Thus, 
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these low porosity TE membranes improve imaging, but can be rate limiting for small molecule transport 
if used in a two chambers system.  
We addressed the need for optical transparency by building the first in vitro barrier models featuring 
nanoporous silicon nitride (NPN) 26. NPN is a durable and highly manufacturable ‘silicon nanomembrane,’ 
a family of ultrathin free-standing porous membranes produced by silicon microfabrication methods 28, 43, 
55. NPN membranes are 50 nm thick NPN with ~ 40 nm pores and a density of 1010 pores/cm2 26. The small 
molecule diffusive permeability of these membranes is a remarkable ~ 0.1 cm/s 56, a value so high that is 
indistinguishable from free diffusion through water in practical assays 27. For our purposes, NPN is also 
superior to the microporous SiO2 nanomembranes previously used to visualize direct HUVEC/ADSC co-
cultures 43 because: 1) The sub-optical pore sizes of NPN give a feature-free background for high quality 
visualizing immune cell/endothelial interactions; 2) Endothelial cell adhesion to NPN is excellent even 
under high levels of shear stress that readily strips endothelial cells from microporous SiO2 (Figure S1).  
In addition to their extraordinary permeability, NPN membranes were superior to any commercially 
available membrane we tested with respect to their optical characteristics and adhesive properties. 
Indeed, the CD34+ ECs grew perfectly on the NPN membrane reaching confluency 24h after seeding and 
building a dense monolayer after 6 days of culture that allowed maintenance of a BLEC monolayer under 
physiological flow. Because the silicon platform enables the facile construction of dual compartment 
culture devices, we readily adapted the co-culture based human in vitro BBB model requiring co-culture of 
CD34+ ECs with pericytes 15. Successful replacement of the pericyte co-culture with PCM in the basal 
compartment further advanced the in vitro BBB model by eliminating contributions from out-of-focus cells 
when imaging the endothelial layer. Using PCM instead of the standard co-culture with pericytes revealed 
only one minor difference with respect to a lack of upregulated expression of ICAM-2 upon stimulation of 
BLECs with TNF-α. However, since ICAM-1 is the major and high affinity ligand for LFA-1 on T cells, this 
result does not invalidate our model to study immune cell trafficking. Moreover, regarding the difference 
in the model’s characteristics, we noticed that after the transfer of the BLECs from the “Transwell® 
mimetic” to the µSiM-CVB flow system, the claudin-5 staining appeared more jagged, which could be a 
sign of a different junctional maturation. Since we measured comparable permeability values of the BLEC 
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monolayer in the two devices, it seems that this does not have a significant impact on the paracellular 
tightness that could modify immune cell interactions with the BLECs. However, this observation my 
become important when adapting this in vitro BBB model for small molecule permeability screenings.  
The next step, which was to apply flow in our µSiM-CVB flow system, took full advantage of the properties 
of the NPN material that help distinguish it from all commercial membrane materials. While its nanoscale 
thinness gives NPN high permeability and makes it excellent for live cell imaging, we also found that the 
ceramic-like membrane is still sufficiently stiff that it remains in focus with the onset of flow and 
throughout more than 30 minutes of continuous recording. The optical imaging quality of T-cell 
interactions observed on the BLECs monolayer using the novel µSiM-CVB flow system were 
indistinguishable from those on glass 32, 57, 58. The µSiM-CVB flow system traps T cells below the BLEC 
monolayer, which does not allow for easy T cell collection and may have consequences for the 
experimental outcomes. Artifical T cell accumulation e.g. when investigating chemokine gradients can be 
avoided by modifying the T-cell numbers superfused over the BLEC monolayer and the time of recording. 
 
Despite currents trends toward increasing complexity in the development of microphysiological systems, 
it was not our goal to achieve an anatomical mimetic of the human BBB by including all the cellular and 
acellular elements of the neurovascular unit. Instead we focused on addressing a specific unmet need in 
the CVB research community: an in vitro platform that enables the observation of live human immune 
cells interacting with a well-characterized human BBB model under flow. The observations of T-cell arrest, 
crawling on, and diapedesis across the BLECs monolayer under physiological flow as well as the observed 
influence of the inflammatory status of BLECs on these interactions, validates the µSiM-CVB for these 
purposes. Simplicity, such as the elimination of the need for co-culture, is one benefit of our platform.  
Moreover, the volumes of the apical channels of both the “Transwell® mimetic” mimetic” and the µSiM-
CVB flow system are less than 20 µL, a feature that will eventually allow the use of small samples of body 
fluids or cells obtained from patients for personalized medicine. Overall, we expect the µSiM-CVB 
platform to open new opportunities to define novel therapeutic targets for neurological disorders ranging 
from neuroinflammation and neurodegeneration to tumor metastasis and for adaptation to investigate 
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other cellular barriers.  
 
Acknowledgements 
We gratefully acknowledge Thomas Andolsek for the initial phase of device manufacturing and the 
support of the Microscopy Imaging Center of the University of Bern. We also gratefully acknowledge 
Daniela Latorre and David Jarrossay for the work they did to collect the T cells.  
 
Author’s contributions 
Britta Engelhardt: Conceptualization; Resources; Supervision; Funding acquisition; Project administration; 
Writing—review and editing. Adrien Mossu: Data curation; Formal analysis; Investigation; Methodology; 
Writing—original draft. Maria Rosito: Data curation; Formal analysis; Investigation; Methodology; 
Writing—original draft. Tejas Khire: Data curation; Formal analysis; Investigation; Methodology; Writing—
original draft. Hung Chung: Data curation; Methodology. Hideaki Nishihara: Data curation; Formal 
analysis; Investigation; Methodology. Isabelle Gruber: Data curation; Formal analysis; Investigation; 
Methodology. Emma Luke: Methodology. Lucie Dehouck: Resources; Methodology. Federica Sallusto: 
Resources; Methodology. Fabien Gosselet: Resources; Methodology; Writing—review and editing. James 
McGrath: Conceptualization; Supervision; Funding acquisition; Project administration; Writing—review 
and editing. 
 
Conflict of interests 
 
J.L.M. declares a competing financial interest as a co-founder and equity holder of SiMPore Inc., a 
commercial manufacturer of NPN and other silicon-based membrane materials.  
 
Supplementary material for this paper can be found at 
http://jcbfm.sagepub.com/content/by/supplemental-data 
  
 20 
References 
 
1. Engelhardt B and Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function 
and dysfunction. Semin Immunopathol 2009; 31: 497-511. 2009/09/26. DOI: 10.1007/s00281-009-0177-0. 
2. Engelhardt B and Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain 
barriers. Trends Immunol 2012; 33: 579-589. 2012/08/29. DOI: 10.1016/j.it.2012.07.004. 
3. Sospedra M and Martin R. Immunology of Multiple Sclerosis. Semin Neurol 2016; 36: 115-127. 
2016/04/27. DOI: 10.1055/s-0036-1579739. 
4. Diebold M and Derfuss T. Immunological treatment of multiple sclerosis. Semin Hematol 2016; 53 
Suppl 1: S54-57. 2016/06/18. DOI: 10.1053/j.seminhematol.2016.04.016. 
5. Martin R, Sospedra M, Rosito M, et al. Current multiple sclerosis treatments have improved our 
understanding of MS autoimmune pathogenesis. Eur J Immunol 2016; 46: 2078-2090. 2016/07/29. DOI: 
10.1002/eji.201646485. 
6. Helms HC, Abbott NJ, Burek M, et al. In vitro models of the blood-brain barrier: An overview of 
commonly used brain endothelial cell culture models and guidelines for their use. J Cereb Blood Flow 
Metab 2016; 36: 862-890. 2016/02/13. DOI: 10.1177/0271678x16630991. 
7. Grant GA, Abbott NJ and Janigro D. Understanding the Physiology of the Blood-Brain Barrier: In 
Vitro Models. News Physiol Sci 1998; 13: 287-293. 2001/06/08. 
8. Steiner O, Coisne C, Engelhardt B, et al. Comparison of immortalized bEnd5 and primary mouse 
brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell 
extravasation. J Cereb Blood Flow Metab 2011; 31: 315-327. 2010/07/08. DOI: 10.1038/jcbfm.2010.96. 
9. Cayrol R, Haqqani AS, Ifergan I, et al. Isolation of human brain endothelial cells and 
characterization of lipid raft-associated proteins by mass spectroscopy. Methods Mol Biol 2011; 686: 275-
295. 2010/11/18. DOI: 10.1007/978-1-60761-938-3_13. 
10. Weksler BB, Subileau EA, Perriere N, et al. Blood-brain barrier-specific properties of a human adult 
brain endothelial cell line. Faseb j 2005; 19: 1872-1874. 2005/09/06. DOI: 10.1096/fj.04-3458fje. 
11. Eigenmann DE, Xue G, Kim KS, et al. Comparative study of four immortalized human brain 
capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture 
conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS 
2013; 10: 33. 2013/11/23. DOI: 10.1186/2045-8118-10-33. 
12. Deli MA, Abraham CS, Kataoka Y, et al. Permeability studies on in vitro blood-brain barrier models: 
physiology, pathology, and pharmacology. Cell Mol Neurobiol 2005; 25: 59-127. 2005/06/21. 
13. Canfield SG, Stebbins MJ, Morales BS, et al. An isogenic blood-brain barrier model comprising 
brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells. J 
Neurochem 2017; 140: 874-888. 2016/12/10. DOI: 10.1111/jnc.13923. 
14. Lippmann ES, Al-Ahmad A, Palecek SP, et al. Modeling the blood-brain barrier using stem cell 
sources. Fluids Barriers CNS 2013; 10: 2. 2013/01/12. DOI: 10.1186/2045-8118-10-2. 
15. Cecchelli R, Aday S, Sevin E, et al. A stable and reproducible human blood-brain barrier model 
derived from hematopoietic stem cells. PLoS One 2014; 9: e99733. 2014/06/18. DOI: 
10.1371/journal.pone.0099733. 
16. Vandenhaute E, Drolez A, Sevin E, et al. Adapting coculture in vitro models of the blood-brain 
barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment 
of transendothelial migration. Lab Invest 2016; 96: 588-598. 2016/02/24. DOI: 10.1038/labinvest.2016.35. 
17. Lyck R, Lecuyer MA, Abadier M, et al. ALCAM (CD166) is involved in extravasation of monocytes 
rather than T cells across the blood-brain barrier. J Cereb Blood Flow Metab 2017; 37: 2894-2909. 
2016/01/01. DOI: 10.1177/0271678x16678639. 
18. Coisne C, Lyck R and Engelhardt B. Live cell imaging techniques to study T cell trafficking across 
the blood-brain barrier in vitro and in vivo. Fluids Barriers CNS 2013; 10: 7. 2013/01/23. DOI: 
10.1186/2045-8118-10-7. 
 21 
19. Martinelli R, Zeiger AS, Whitfield M, et al. Probing the biomechanical contribution of the 
endothelium to lymphocyte migration: diapedesis by the path of least resistance. J Cell Sci 2014; 127: 
3720-3734. 2014/07/09. DOI: 10.1242/jcs.148619. 
20. Shulman Z and Alon R. Real-time analysis of integrin-dependent transendothelial migration and 
integrin-independent interstitial motility of leukocytes. Methods Mol Biol 2012; 757: 31-45. 2011/09/13. 
DOI: 10.1007/978-1-61779-166-6_3. 
21. Munir H, Rainger GE, Nash GB, et al. Analyzing the effects of stromal cells on the recruitment of 
leukocytes from flow. J Vis Exp 2015: e52480. 2015/01/16. DOI: 10.3791/52480. 
22. Garberg P, Ball M, Borg N, et al. In vitro models for the blood-brain barrier. Toxicol In Vitro 2005; 
19: 299-334. 2005/02/17. DOI: 10.1016/j.tiv.2004.06.011. 
23. Abbott NJ, Patabendige AA, Dolman DE, et al. Structure and function of the blood-brain barrier. 
Neurobiol Dis 2010; 37: 13-25. 2009/08/12. DOI: 10.1016/j.nbd.2009.07.030. 
24. Cinamon G, Shinder V and Alon R. Shear forces promote lymphocyte migration across vascular 
endothelium bearing apical chemokines. Nat Immunol 2001; 2: 515-522. 2001/05/29. DOI: 
10.1038/88710. 
25. Schreiber TH, Shinder V, Cain DW, et al. Shear flow-dependent integration of apical and 
subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep 
paradigm. Blood 2007; 109: 1381-1386. 2006/10/14. DOI: 10.1182/blood-2006-07-032995. 
26. DesOrmeaux JP, Winans JD, Wayson SE, et al. Nanoporous silicon nitride membranes fabricated 
from porous nanocrystalline silicon templates. Nanoscale 2014; 6: 10798-10805. 2014/08/12. DOI: 
10.1039/c4nr03070b. 
27. Snyder JL, Clark A, Jr., Fang DZ, et al. An experimental and theoretical analysis of molecular 
separations by diffusion through ultrathin nanoporous membranes. J Memb Sci 2011; 369: 119-129. 
2011/02/08. DOI: 10.1016/j.memsci.2010.11.056. 
28. Striemer CC, Gaborski TR, McGrath JL, et al. Charge- and size-based separation of macromolecules 
using ultrathin silicon membranes. Nature 2007; 445: 749-753. 2007/02/16. DOI: 10.1038/nature05532. 
29. Pedroso DC, Tellechea A, Moura L, et al. Improved survival, vascular differentiation and wound 
healing potential of stem cells co-cultured with endothelial cells. PLoS One 2011; 6: e16114. 2011/02/02. 
DOI: 10.1371/journal.pone.0016114. 
30. Cecchelli R, Dehouck B, Descamps L, et al. In vitro model for evaluating drug transport across the 
blood-brain barrier. Adv Drug Deliv Rev 1999; 36: 165-178. 2000/06/06. 
31. Coisne C, Dehouck L, Faveeuw C, et al. Mouse syngenic in vitro blood-brain barrier model: a new 
tool to examine inflammatory events in cerebral endothelium. Lab Invest 2005; 85: 734-746. 2005/05/24. 
DOI: 10.1038/labinvest.3700281. 
32. Steiner O, Coisne C, Cecchelli R, et al. Differential roles for endothelial ICAM-1, ICAM-2, and 
VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier 
endothelium. J Immunol 2010; 185: 4846-4855. 2010/09/24. DOI: 10.4049/jimmunol.0903732. 
33. Engen SA, Valen Rukke H, Becattini S, et al. The oral commensal Streptococcus mitis shows a 
mixed memory Th cell signature that is similar to and cross-reactive with Streptococcus pneumoniae. PLoS 
One 2014; 9: e104306. 2014/08/15. DOI: 10.1371/journal.pone.0104306. 
34. Sallusto F, Schaerli P, Loetscher P, et al. Rapid and coordinated switch in chemokine receptor 
expression during dendritic cell maturation. Eur J Immunol 1998; 28: 2760-2769. 1998/10/01. DOI: 
10.1002/(sici)1521-4141(199809)28:09&#60;2760::aid-immu2760&#62;3.0.co;2-n. 
35. Enzmann G, Mysiorek C, Gorina R, et al. The neurovascular unit as a selective barrier to 
polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury. Acta Neuropathol 
2013; 125: 395-412. 2012/12/28. DOI: 10.1007/s00401-012-1076-3. 
36. Takeshita Y, Obermeier B, Cotleur A, et al. An in vitro blood-brain barrier model combining shear 
stress and endothelial cell/astrocyte co-culture. J Neurosci Methods 2014; 232: 165-172. 2014/05/27. DOI: 
10.1016/j.jneumeth.2014.05.013. 
37. Goncharova V and Khaldoyanidi SK. A novel three-dimensional flow chamber device to study 
chemokine-directed extravasation of cells circulating under physiological flow conditions. J Vis Exp 2013: 
e50959. 2013/07/31. DOI: 10.3791/50959. 
 22 
38. Xu H, Li Z, Yu Y, et al. A dynamic in vivo-like organotypic blood-brain barrier model to probe 
metastatic brain tumors. Sci Rep 2016; 6: 36670. 2016/11/11. DOI: 10.1038/srep36670. 
39. Herland A, van der Meer AD, FitzGerald EA, et al. Distinct Contributions of Astrocytes and 
Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip. PLoS One 2016; 
11: e0150360. 2016/03/02. DOI: 10.1371/journal.pone.0150360. 
40. Neuhaus W, Lauer R, Oelzant S, et al. A novel flow based hollow-fiber blood-brain barrier in vitro 
model with immortalised cell line PBMEC/C1-2. J Biotechnol 2006; 125: 127-141. 2006/05/30. DOI: 
10.1016/j.jbiotec.2006.02.019. 
41. Cucullo L, Couraud PO, Weksler B, et al. Immortalized human brain endothelial cells and flow-
based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow 
Metab 2008; 28: 312-328. 2007/07/05. DOI: 10.1038/sj.jcbfm.9600525. 
42. Erbeldinger N, Rapp F, Ktitareva S, et al. Measuring Leukocyte Adhesion to (Primary) Endothelial 
Cells after Photon and Charged Particle Exposure with a Dedicated Laminar Flow Chamber. Front Immunol 
2017; 8: 627. 2017/06/18. DOI: 10.3389/fimmu.2017.00627. 
43. Mazzocchi AR, Man AJ, DesOrmeaux J-PS, et al. Porous Membranes Promote Endothelial 
Differentiation of Adipose-Derived Stem Cells and Perivascular Interactions. Cellular and Molecular 
Bioengineering 2014; 7: 369-378. journal article. DOI: 10.1007/s12195-014-0354-7. 
44. Carter RN, Casillo SM, Mazzocchi AR, et al. Ultrathin transparent membranes for cellular barrier 
and co-culture models. Biofabrication 2017; 9: 015019. 2017/02/01. DOI: 10.1088/1758-5090/aa5ba7. 
45. Chung HH, Casillo SM, Perry SJ, et al. Porous Substrates Promote Endothelial Migration at the 
Expense of Fibronectin Fibrillogenesis. ACS Biomater Sci Eng 2018; 4: 222-230. 2018/05/02. DOI: 
10.1021/acsbiomaterials.7b00792. 
46. Chung HH, Chan CK, Khire TS, et al. Highly permeable silicon membranes for shear free 
chemotaxis and rapid cell labeling. Lab Chip 2014; 14: 2456-2468. 2014/05/23. DOI: 10.1039/c4lc00326h. 
47. Johnson LM, Gao L, Shields IC, et al. Elastomeric microparticles for acoustic mediated 
bioseparations. J Nanobiotechnology 2013; 11: 22. 2013/07/03. DOI: 10.1186/1477-3155-11-22. 
48. Bo L, Peterson JW, Mork S, et al. Distribution of immunoglobulin superfamily members ICAM-1, -2, 
-3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions. J Neuropathol Exp Neurol 1996; 55: 1060-
1072. 1996/10/01. 
49. Drolez A, Vandenhaute E, Julien S, et al. Selection of a Relevant In Vitro Blood-Brain Barrier Model 
to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines. PLoS One 2016; 11: e0151155. 
2016/03/10. DOI: 10.1371/journal.pone.0151155. 
50. Samuel W, Jaworski C, Postnikova OA, et al. Appropriately differentiated ARPE-19 cells regain 
phenotype and gene expression profiles similar to those of native RPE cells. Mol Vis 2017; 23: 60-89. 
2017/03/31. 
51. Hawkins BT and Davis TP. The blood-brain barrier/neurovascular unit in health and disease. 
Pharmacol Rev 2005; 57: 173-185. 2005/05/26. DOI: 10.1124/pr.57.2.4. 
52. Engelhardt B and Liebner S. Novel insights into the development and maintenance of the blood-
brain barrier. Cell Tissue Res 2014; 355: 687-699. 2014/03/05. DOI: 10.1007/s00441-014-1811-2. 
53. Bhatia SN and Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol 2014; 32: 760-772. 
2014/08/06. DOI: 10.1038/nbt.2989. 
54. Walter FR, Valkai S, Kincses A, et al. A versatile lab-on-a-chip tool for modeling biological barriers. 
Sensors and Actuators B: Chemical 2016; 222: 1209-1219. DOI: https://doi.org/10.1016/j.snb.2015.07.110. 
55. de Mesy Bentley KL, Trombetta R, Nishitani K, et al. Evidence of Staphylococcus Aureus 
Deformation, Proliferation, and Migration in Canaliculi of Live Cortical Bone in Murine Models of 
Osteomyelitis. J Bone Miner Res 2017; 32: 985-990. 2016/12/10. DOI: 10.1002/jbmr.3055. 
56. Kim E, Xiong H, Striemer CC, et al. A structure-permeability relationship of ultrathin nanoporous 
silicon membrane: a comparison with the nuclear envelope. J Am Chem Soc 2008; 130: 4230-4231. 
2008/03/08. DOI: 10.1021/ja711258w. 
57. Shulman Z, Shinder V, Klein E, et al. Lymphocyte crawling and transendothelial migration require 
chemokine triggering of high-affinity LFA-1 integrin. Immunity 2009; 30: 384-396. 2009/03/10. DOI: 
10.1016/j.immuni.2008.12.020. 
 23 
58. Rudolph H, Klopstein A, Gruber I, et al. Postarrest stalling rather than crawling favors CD8(+) over 
CD4(+) T-cell migration across the blood-brain barrier under flow in vitro. Eur J Immunol 2016; 46: 2187-
2203. 2016/06/25. DOI: 10.1002/eji.201546251. 
 24 
Figure legends 
 
Figure 1. CD34+ - derived ECs grow to confluent monolayer on the nanoporous silicon nitride membrane.  
(A) Schematic of the nanoporous silicon nitride membrane used for the cell culture experiments. The free-
standing membrane region is a 2 mm x 0.7 mm window in the center of a 5.4 mm x 5.4 mm membrane 
‘chip’. (B) The cross-sectional (A-A) schematic of the membrane. The bulk substrate consists of 300 
microns of crystalline silicon, which is etched at the center to remove the bulk leaving a free standing 50 
nm thin silicon nitride membrane. The manufacturing of these membranes was described before 26. (C) 
Optical micrograph of the membrane chip. (D) Scanning electron micrograph of the porous membrane 
demonstrating the ultrathin nature and porous structure of the silicon nitride membrane (> 20% porosity 
in this example). (E) Phase contrast pictures of CD34+ -derived ECs adhering and growing to confluent 
monolayer on the NPN membranes from day 0 until day 5 after plating. The CD34+ ECs adhere on the NPN 
membrane after 1 to 2 hours and start to grow to form a confluent monolayer between 1 and 2 days of 
culture. Cellular density increases until day 5. Scale bar, 100 μm. 
 
Figure 2. Induction of BBB characteristics in CD34+ ECs by pericyte-conditioned medium 
(A) Scheme of the different culture conditions used to test the BBB induction (B) Timeline of experimental 
procedures: scheme of the PCM production and luminal or abluminal administration to the CD34+-derived 
ECs followed by Lucifer Yellow (LY) permeability assay, immunofluorescence stainings and live cell imaging 
under physiological flow. (C) Lucifer Yellow (LY) permeability assay: the permeability was measured across 
monocultures of CD34+-derived ECs (monoculture), CD34+ -derived ECs co-cultured with pericytes (co-
culture), or pericyte-conditioned medium at the abluminal (PCM abluminal) or luminal (PCM luminal) side. 
Bars show means ± SD of n= 3 independent experiments performed at least in duplicate for each 
condition. Statistical analysis: one-way ANOVA followed by Dunnett’s multiple comparison test **** p < 
0.0001. (D) Immunofluorescence stainings for the junctional proteins VE-cadherin (red), ZO-1 (green), 
claudin-5 (green) and for F-actin (red) in CD34+ -derived ECs grown in monoculture, in co-culture with 
pericytes or with PCM administered at the abluminal or luminal side are shown. The pictures show a more 
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jagged VE-cadherin and ZO-1 fluorescent staining in the co-culture and PCM conditions (arrows). The 
claudin 5 staining is also more important and continuous in the co-culture and PCM abluminal conditions 
(arrows). Scale bar, 50 μm. (E) Immunofluorescence staining for ICAM-1 and ICAM-2 (red), VCAM-1 
(green), on CD34+ -derived ECs grown in co-culture with pericytes or with PCM administered at the 
abluminal side, non-stimulated (NS) or stimulated with TNF-α for 16h. Scale bar, 20 μm. 
 
Figure 3. CD34+ -derived ECs grown on nanoporous silicon nitride membranes establish BLECs 
characteristics.  
(A) Design of a “Transwell mimetic” device developed to culture CD34+ -derived ECs in the membrane 
compartment of the NPN membrane, in close proximity to the pericyte-conditioned medium (PCM) in the 
basal compartment. The device is constructed from poly dimethyl siloxane (PDMS) and silicone gaskets 
sandwiched together using UV-ozone bonding. Note the transparent nature of the whole device in 
general, and specifically of the silicon membrane used to support cell growth. The schematic is shown on 
the right (drawn not to scale). Molecular tracers can be added to the membrane compartment and 
collected from the basal compartment for fluorometric analysis. (B) The permeability Lucifer Yellow (PeLY) 
was measured across monolayers of CD34+ -derived ECs grown alone (monoculture) and CD34+ -derived 
ECs cultured in the presence of PCM in the abluminal compartment. The values show mean ± SD of 11 
customized devices for the CD34+ -derived ECs mono-cultures and 12 devices for the CD34+ ECs cultured in 
the presence of abluminal PCM. Statistical analysis: Student’s t-test ****p < 0.0001. (C) 
Immunofluorescence staining on BLECs, induced by PCM in the basal compartment, for the junctional 
markers ZO-1 (green), VE-cadherin (green) and claudin-5 (green). Each staining is representative of 2 
independent experiment performed on 2 distinct devices, Scale bar, 20 μm. (D) Immunofluorescence 
staining for ICAM-1 and ICAM-2 (red), VCAM-1 (green), and F-actin (red) on BLECs unstimulated (NS) or 
stimulated with TNF-α for 16h. Each staining is representative of 2 independent experiment performed on 
2 distinct devices. Scale bar, 20 μm.  
 
Figure 4: Assembly of the µSiM-CVB flow system  
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(A) Photograph and (B) exploded view of the assembled µSiM-CVB flow system. Note the optical 
transparency of the assembled device components. The supporting layer of the device is a thin #1.5 glass 
cover slip. All the silicone layers (blue/green/teal) are 300 microns thick.  
‘Top’ and ‘Bottom’ channels perfuse media, while the ‘Top Connecting Layer’ and ‘Bottom Connecting 
Layer’ demarcate the top and bottom compartments respectively. The ‘Membrane Layer’ provides a 
supporting framework for the membrane. The topmost PDMS reservoirs store the excess media and are 
exposed to the outside-incubator environment for gas exchange. Similarly, all the other device 
components are all gas-permeable and are sterilized by autoclaving. During flow set-up, the 18 gauge 
needles fitted with silicone tubings are inserted in the 4 holes in the Top Connecting Layer. (C) 
Immunofluorescence staining on BLECs grown in the µSiM-CVB flow system, induced by PCM in the basal 
compartment, for the junctional markers ZO-1 (green), VE-cadherin (green) and claudin-5 (green). Each 
staining is representative of 2 independent experiment performed on 2 distinct devices, Scale bar, 20 μm. 
(D) Schematic of the settings for live cell imaging of the T cell/BLEC interactions under flow. T cells are 
perfused on the apical (top) side of the device, and migrate in a multi-step process across the BLEC 
monolayer. T cells can also crawl in the subendothelial layer above the membrane. The 50 nm pores in the 
silicon membrane prevent their passage into the basal (bottom) compartment of the device. The working 
distance of the device (distance between microscope objective and T cells) is 1.180 mm. (E) A temporal 
snapshot to illustrate the resolution and focusing-stability under flow from two videos recorded at 10x 
magnification (EC Plan-Neofluar 10X/0.30 Ph1). BLECs were cultured and TNF-activated as described in the 
main text. The pictures show the BLECs to illustrate image clarity and the stability of focus from the start 
(00min) to the end (34min55s) of the recording session under flow. The arrows show area where the 
BLECs are elongated after stimulation with TNF-α. The time is displayed on the top left of the video 
(min:sec format). Scale = 50 µm. 
 
Figure 5. in vitro live cell imaging of the T cell-BBB interactions under flow  
(A) A temporal snapshot illustrating the different T cell-BLECs interactions has been made with several 
frames taken from a video recorded with a 20x magnification (LD Plan-Neofluar 20X/0.4 Korr Ph2). The 
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CD34+ ECs were cultured in the top channel of the flow chamber with the PCM in the bottom channel for 
6 days and the CD34+ ECs were stimulated with TNF (10 ng/mL) 16h before starting to record the video. 
Th1 cells are allowed to accumulate on the BLECs monolayer at a low flow rate of 0.1 dyne/cm2 for 4 min 
from the first frame after the first Th1 cells appear in the field of view, then the flow rate was set to 1.5 
dyne/cm2 for 30 min (shear phase). Each row is showing a specific behavior of the Th1 cells with the BLECs 
with the example of 2 different cells one highlighted with a blue arrow and the other one with a yellow 
arrow. The first row illustrates the diapedesis event where T cells start to arrest (1min20s) and then 
polarize and firmly adhere (5min) to the BLECs. Then the T cells start to transmigrate through the BLECs 
monolayer (5min35s) and take more (23min, blue arrow) or less (7min45s, yellow arrow) time to 
complete diapedesis. The pore size of 50 nm prevents the leukocytes from crossing the silicon membrane, 
and cells are trapped in the subendothelial spaces and can still be followed and identified by their darker 
gray shape in comparison of the BLECs monolayer (23min). The second row illustrates the crawling event 
where T cells first arrest (1min20s) and then polarize and firmly adhere (3min) to the BLECs. Then the T 
cells start to form a leading edge with a lot of small protrusions (5min25s, blue arrow and 13min45s, 
yellow arrow) and actively move on the BLECs against the direction of the flow until they even disappear 
from the field of view (13min45s, blue arrow and 29min50s, yellow arrow). The third row illustrates the 
probing event where T cells first arrest (1min20s) and then polarize and firmly adhere (4min40s) to the 
BLECs. Then the T cells remained stationary without displacing beyond a distance exceeding their own 
diameter and presenting the ability to greatly modulate their shape, sending a lot of dynamic cellular 
protrusions around them (from 7min30s to 26min). The red arrow shows the direction of flow and the 
time is displayed on the top left of the video (min:sec format). Scale = 20 µm. 
(B) Analysis of the arrest and postarrest T-cell interactions with NS and TNF-α stimulated BLECs in the field 
of view of the videos recorded with a 10x magnification (example in video 1 and 2) under physiological 
flow (1.5 dyne/cm2) for 30 min. T cells remaining arrested to the BLECs monolayer where quantified (total) 
at the end of the accumulation phase (0.1 dyne/cm2 for 4 min from the time the first T cells appear in the 
field of view). Then post-arrest T cell behavior on the BLECs monolayer under flow was analyzed such as 
each T cell was assigned to one of 4 categories as follows: diapedesis, crawling, probing and detaching. 
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Values are means ± SD for 10 assays for each condition. Statistical analysis: t-test * p < 0.05, ** p < 0.01, p 
< 0.001, ****p < 0.0001. 
 
